🇺🇸 FDA
Pipeline program

NT-301 1 mg

NT-301-101

Phase 1 other completed

Quick answer

NT-301 1 mg for Tolerability of NT-301 Nasal Spray is a Phase 1 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Tolerability of NT-301 Nasal Spray
Phase
Phase 1
Modality
other
Status
completed

Clinical trials